FIELD: medicine.
SUBSTANCE: invention relates to a method of treating skin ulcers in a mammalian subject. A method of treating skin ulcers in a mammalian subject comprising administering a polypeptide of SEQ ID NO: 4, where the polypeptide is administered topically and applied to the surface of the damaged body part and, in this case, the dose/each dose has an amount of 0.3–6 μg of the polypeptide per mm2 of the treated damaged body surface, which is 0.3–6 μg/mm2.
EFFECT: above invention makes it possible to treat skin ulcers in mammals.]
12 cl, 27 dwg, 9 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMOLOGICAL DISORDERS | 2020 |
|
RU2812055C1 |
| CHLORIDE-INDUCED PROKARYOTIC EXPRESSION SYSTEM | 2019 |
|
RU2812766C2 |
| NEW TYPES OF TREATMENT | 2015 |
|
RU2732378C2 |
| THERAPEUTIC AND COSMETIC USE OF SEROTYPE E NEUROTOXIN BOTULINUM | 2019 |
|
RU2800604C2 |
| MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, COMPOSITIONS CONTAINING IT, AND THEIR APPLICATION METHODS | 2017 |
|
RU2756313C2 |
| COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2804815C2 |
| NOVEL PROTEIN CONJUGATE AND USE THEREOF FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS, OBESITY AND DIABETES | 2021 |
|
RU2822001C1 |
| TREATMENT OF DISEASES BY MEANS OF EXPRESSION OF ENZYME WITH DEOXYRIBONUCLEASE (DNase) ACTIVITY IN LIVER | 2019 |
|
RU2773691C2 |
| ANTIBODIES TO CD38 AND PHARMACEUTICAL COMPOSITIONS BASED THEREON FOR TREATMENT OF AUTOIMMUNE DISEASE MEDIATED BY AUTOANTIBODIES | 2020 |
|
RU2809565C2 |
| ANTIBODIES TO CD40 FOR USE IN THE TREATMENT OF SJOGREN'S SYNDROME | 2018 |
|
RU2790558C2 |
